Weight Management
Setmelanotide Phase 2 Data Show BMI, Fat Mass Gains in PWS
Six-month interim results reinforce MC4R pathway as a viable therapeutic target, with Phase 3 development now in the ra…
Six-month interim results reinforce MC4R pathway as a viable therapeutic target, with Phase 3 development now in the ra…
With BHB blends flooding e-commerce channels, operators and formulators face mounting pressure to substantiate ketone-d…